H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
6.39
+0.87 (15.78%)
At close: Aug 29, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $6.40 billion as of September 15, 2025. Its market cap has decreased by -7.00% in one year.
Market Cap
6.40B
Enterprise Value
8.13B
Revenue
3.70B
Ranking
n/a
PE Ratio
11.66
Stock Price
$6.39
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 6.40B, an increase of 40.93%. That is a compound annual growth rate of 11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 6.38B | 16.27% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |